We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Natural Resource Partners LP (NRP - Free Report) delivered first-quarter 2019 adjusted earnings of $1.75 per unit, which beat the Zacks Consensus Estimate of $1.30 by 34.6%. Moreover, the bottom line improved 56.3% from the year-ago quarter’s figure.
Total Revenues
In the quarter, total revenues amounted to $67 million and beat the Zacks Consensus Estimate of $62 million by 8%. Also, the top line improved 11.5% from the year-ago quarter’s level.
The upside was driven by stable performance from metallurgical and thermal coal properties. Net income was driven by higher average coal royalty revenue per ton and increased coal overriding royalty revenues from the Williamson property in the Illinois Basin.
Natural Resource Partners LP Price, Consensus and EPS Surprise
The Coal Royalty and Other segment contributed 82.6% to total revenues in the first quarter. Also, the Soda Ash segment contributed 17.4% to revenues.
Total operating expenses in the quarter rose 8.2% to $17.1 million from $15.8 million in the prior-year quarter. The uptick was caused by higher operating and maintenance expenses in the quarter.
Interest expenses declined 21.1% to $14.2 million from $18 million in the year-ago quarter.
Financial Condition
Natural Resource had cash and cash equivalents of $112.4 million as of Mar 31, 2019, up from $101.8 million as of Dec 31, 2018.
The partnership continues to lower outstanding debt levels. Long-term debt was $541.6 million as of Mar 31, 2019, down from $557.5 million as of Dec 31, 2018.
Cash flow from operating activities in the first quarter was $22.8 million, up from $17.4 million in the year-ago quarter.
Arch Coal Inc. (ARCH - Free Report) delivered first-quarter 2019 operating earnings of $3.36 per share, which beat the Zacks Consensus Estimate of $2.53 by 32.8%.
Alliance Resource Partners, L.P. (ARLP - Free Report) generated first-quarter 2019 operating earnings of $1.03 per unit, which topped the Zacks Consensus Estimate of 69 cents by 49%.
Peabody Energy Corp. (BTU - Free Report) announced first-quarter 2019 earnings of $1.15 per share, which surpassed the Zacks Consensus Estimate of 50 cents by 130%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Natural Resource (NRP) Beats Q1 Earnings & Revenue Estimates
Natural Resource Partners LP (NRP - Free Report) delivered first-quarter 2019 adjusted earnings of $1.75 per unit, which beat the Zacks Consensus Estimate of $1.30 by 34.6%. Moreover, the bottom line improved 56.3% from the year-ago quarter’s figure.
Total Revenues
In the quarter, total revenues amounted to $67 million and beat the Zacks Consensus Estimate of $62 million by 8%. Also, the top line improved 11.5% from the year-ago quarter’s level.
The upside was driven by stable performance from metallurgical and thermal coal properties. Net income was driven by higher average coal royalty revenue per ton and increased coal overriding royalty revenues from the Williamson property in the Illinois Basin.
Natural Resource Partners LP Price, Consensus and EPS Surprise
Natural Resource Partners LP Price, Consensus and EPS Surprise | Natural Resource Partners LP Quote
Highlights of the Release
The Coal Royalty and Other segment contributed 82.6% to total revenues in the first quarter. Also, the Soda Ash segment contributed 17.4% to revenues.
Total operating expenses in the quarter rose 8.2% to $17.1 million from $15.8 million in the prior-year quarter. The uptick was caused by higher operating and maintenance expenses in the quarter.
Interest expenses declined 21.1% to $14.2 million from $18 million in the year-ago quarter.
Financial Condition
Natural Resource had cash and cash equivalents of $112.4 million as of Mar 31, 2019, up from $101.8 million as of Dec 31, 2018.
The partnership continues to lower outstanding debt levels. Long-term debt was $541.6 million as of Mar 31, 2019, down from $557.5 million as of Dec 31, 2018.
Cash flow from operating activities in the first quarter was $22.8 million, up from $17.4 million in the year-ago quarter.
Zacks Rank
Natural Resource currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Other Coal Releases
Arch Coal Inc. (ARCH - Free Report) delivered first-quarter 2019 operating earnings of $3.36 per share, which beat the Zacks Consensus Estimate of $2.53 by 32.8%.
Alliance Resource Partners, L.P. (ARLP - Free Report) generated first-quarter 2019 operating earnings of $1.03 per unit, which topped the Zacks Consensus Estimate of 69 cents by 49%.
Peabody Energy Corp. (BTU - Free Report) announced first-quarter 2019 earnings of $1.15 per share, which surpassed the Zacks Consensus Estimate of 50 cents by 130%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>